Claim Drafting Considering the Amgen v. Sanofi US Supreme Court Decision

The US Supreme Court held that the patent specification “must enable the full scope of the invention as defined by its claims” and that the “more one claims, the more one must enable” in its decision on Amgen v. Sanofi in late May.

This webinar will cover the ruling in Amgen and the Court’s reasonings and provide guidance claim drafters in the life science field should keep in mind considering the implications from the decision.

Please click here to see the schedule of upcoming events, as well as past materials and videos.

Questions?

Please contact Ai Isono.